Keros Therapeutics, Inc. ( KROS) - Key Metrics
KROS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.01 | -$0.63 | -$0.73 | -$0.74 |
| 2025Q3 | $0.35 | -$0.18 | $0.08 | $0.08 |
| 2025Q2 | $0.45 | -$0.76 | -$0.73 | -$0.75 |
| 2025Q1 | $5.21 | $3.66 | $3.97 | $3.96 |
KROS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -8.08 |
| 2025Q3 | ? | -22.07 |
| 2025Q2 | ? | -4.42 |
| 2025Q1 | ? | 0.70 |
KROS
Price: $10.50
52 week price:
Earnings Per Share: -2.53 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 412500
Market Capitalization: 336.0 million